GSE228357 OGA knockdown 2 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE228357_OGA knockdown_2_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE228357_OGA knockdown_2_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE228357_OGA knockdown_2_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE228357_OGA knockdown_2_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

H19 imprinted maternally expressed transcript

Gene

small nucleolar RNA host gene 1

Gene

THAP9 antisense RNA 1

Gene

small nucleolar RNA host gene 3

Gene

PAX8 antisense RNA 1

Gene

OIP5 antisense RNA 1

Gene

general transcription factor IIi pseudogene 4

Gene

urothelial cancer associated 1

Gene

family with sequence similarity 225 member A

Gene

HOXA11 antisense RNA

  • Gene

    H19 imprinted maternally expressed transcript


  • Gene

    small nucleolar RNA host gene 1


  • Gene

    THAP9 antisense RNA 1


  • Gene

    small nucleolar RNA host gene 3


  • Gene

    PAX8 antisense RNA 1


  • Gene

    OIP5 antisense RNA 1


  • Gene

    general transcription factor IIi pseudogene 4


  • Gene

    urothelial cancer associated 1


  • Gene

    family with sequence similarity 225 member A


  • Gene

    HOXA11 antisense RNA

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.